Cargando…

Humoral Immune Response after anti-SARS-CoV-2 Vaccine “Booster” Dose in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)

Detalles Bibliográficos
Autores principales: Sgherza, Nicola, Curci, Paola, Rizzi, Rita, Larocca, Angela Maria Vittoria, Vimercati, Luigi, Tafuri, Silvio, Chironna, Maria, Musto, Pellegrino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833302/
https://www.ncbi.nlm.nih.gov/pubmed/36660353
http://dx.doi.org/10.4084/MJHID.2023.011
_version_ 1784868208707108864
author Sgherza, Nicola
Curci, Paola
Rizzi, Rita
Larocca, Angela Maria Vittoria
Vimercati, Luigi
Tafuri, Silvio
Chironna, Maria
Musto, Pellegrino
author_facet Sgherza, Nicola
Curci, Paola
Rizzi, Rita
Larocca, Angela Maria Vittoria
Vimercati, Luigi
Tafuri, Silvio
Chironna, Maria
Musto, Pellegrino
author_sort Sgherza, Nicola
collection PubMed
description
format Online
Article
Text
id pubmed-9833302
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Università Cattolica del Sacro Cuore
record_format MEDLINE/PubMed
spelling pubmed-98333022023-01-18 Humoral Immune Response after anti-SARS-CoV-2 Vaccine “Booster” Dose in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) Sgherza, Nicola Curci, Paola Rizzi, Rita Larocca, Angela Maria Vittoria Vimercati, Luigi Tafuri, Silvio Chironna, Maria Musto, Pellegrino Mediterr J Hematol Infect Dis Scientific Letter Università Cattolica del Sacro Cuore 2023-01-01 /pmc/articles/PMC9833302/ /pubmed/36660353 http://dx.doi.org/10.4084/MJHID.2023.011 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Scientific Letter
Sgherza, Nicola
Curci, Paola
Rizzi, Rita
Larocca, Angela Maria Vittoria
Vimercati, Luigi
Tafuri, Silvio
Chironna, Maria
Musto, Pellegrino
Humoral Immune Response after anti-SARS-CoV-2 Vaccine “Booster” Dose in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
title Humoral Immune Response after anti-SARS-CoV-2 Vaccine “Booster” Dose in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
title_full Humoral Immune Response after anti-SARS-CoV-2 Vaccine “Booster” Dose in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
title_fullStr Humoral Immune Response after anti-SARS-CoV-2 Vaccine “Booster” Dose in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
title_full_unstemmed Humoral Immune Response after anti-SARS-CoV-2 Vaccine “Booster” Dose in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
title_short Humoral Immune Response after anti-SARS-CoV-2 Vaccine “Booster” Dose in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
title_sort humoral immune response after anti-sars-cov-2 vaccine “booster” dose in patients with monoclonal gammopathy of undetermined significance (mgus)
topic Scientific Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833302/
https://www.ncbi.nlm.nih.gov/pubmed/36660353
http://dx.doi.org/10.4084/MJHID.2023.011
work_keys_str_mv AT sgherzanicola humoralimmuneresponseafterantisarscov2vaccineboosterdoseinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus
AT curcipaola humoralimmuneresponseafterantisarscov2vaccineboosterdoseinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus
AT rizzirita humoralimmuneresponseafterantisarscov2vaccineboosterdoseinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus
AT laroccaangelamariavittoria humoralimmuneresponseafterantisarscov2vaccineboosterdoseinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus
AT vimercatiluigi humoralimmuneresponseafterantisarscov2vaccineboosterdoseinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus
AT tafurisilvio humoralimmuneresponseafterantisarscov2vaccineboosterdoseinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus
AT chironnamaria humoralimmuneresponseafterantisarscov2vaccineboosterdoseinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus
AT mustopellegrino humoralimmuneresponseafterantisarscov2vaccineboosterdoseinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus